Lexicon Pharma (LXRX) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.38 -2.06%
Financial Fact:
Loss from operations: -34.93M
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Loss from operations: -34.93M
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.37), $0.04 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $20.1 million versus the consensus estimate of $12.36 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Humacyte, Inc. (HUMA) Misses Q2 EPS by 7c
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
